The study wishes to examine whether "extended" antipsychotic treatment, in this case,
antipsychotic treatment every other day, is as effective as daily treatment. It is also
evaluating whether there may be differences in terms of side effects.
Participants will be randomly assigned to either the treatment as usual group (i.e., taking
antipsychotic daily) or the extended dosing group (i.e., taking antipsychotic one day on, one
day off). That means, like flipping a coin, there is a 50/50 chance that participants will
continue on daily dosing of your antipsychotic or have it switched to every other day dosing.
This study will last for 1 year. Participants will be evaluated at the beginning and every
two weeks during the first 6 months, with visits once every 4 weeks for the final 6 months.
In total, participants will make 22 visits over 52 weeks to the investigator's office.
The investigators hypothesize that with ED, there will be no change in symptom severity but
improvement in the frequency and severity of side effects, wellbeing, and functioning.